CARRIE LONG: Open Payments
NPI 1619323623 · BEDFORD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 89 payments from 15 companies in 2025. Trend: 2023 $1,045 · 2024 $1,064 · 2025 $1,646
Food & beverage: $1,635Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $286 |
| Vanda Pharmaceuticals Inc. | 10 | $240 |
| Alkermes, Inc. | 15 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $179 |
| Otsuka America Pharmaceutical, Inc. | 10 | $160 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
| Lundbeck LLC | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $90 |
| Tris Pharma Inc | 4 | $72 |
| Axsome Therapeutics, Inc. | 4 | $71 |
Products named: VRAYLAR, REXULTI, FANAPT, ARISTADA, CAPLYTA, COBENFY, Dyanavel XR, Auvelity.
Industry payments across IN — which companies pay providers there.
